Aurinia Pharmaceuticals (AUPH) Payables (2016 - 2026)
Aurinia Pharmaceuticals' (AUPH) quarterly Payables came in at $2.7 million in Q1 2026, down 36.94% YoY from $4.2 million in Q1 2025, and down 19.68% on a QoQ basis from $3.3 million in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Payables (2016 - 2026) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 11 years of Payables data on file, last reported at $2.7 million in Q1 2026.
- Quarterly Payables fell 36.94% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (down 36.94% YoY) and the FY2025 annual result came in at $3.3 million, down 36.13% from the prior year.
- Payables eased to $2.7 million in Q1 2026, from $3.3 million in the prior quarter.
- In the past five years, Payables ranged from a high of $56.8 million in Q3 2024 to a low of $2.2 million in Q3 2025.
- A 5-year average of $27.2 million and a median of $32.4 million in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables soared 82.7% — and 2025, when it slumped 96.1%.
- Tracing AUPH's Payables over 5 years: stood at $40.0 million in 2022, then plunged by 89.18% to $4.3 million in 2023, then gained by 19.88% to $5.2 million in 2024, then plunged by 36.13% to $3.3 million in 2025, then decreased by 19.68% to $2.7 million in 2026.
- The last three Payables figures came in at $2.7 million (Q1 2026), $3.3 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.61 Bn | 76.67 Mn | 1.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.74 Mn |
| Mar 31, 2026 | 2.66 Mn |
| Dec 31, 2025 | 3.31 Mn |
| Sep 30, 2025 | 2.21 Mn |
| Jun 30, 2025 | 3.31 Mn |
| Mar 31, 2025 | 4.22 Mn |
| Dec 31, 2024 | 5.19 Mn |
| Sep 30, 2024 | 56.77 Mn |
| Jun 30, 2024 | 56.46 Mn |
| Mar 31, 2024 | 50.27 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Sep 30, 2023 | 52.31 Mn |
| Jun 30, 2023 | 41.38 Mn |
| Mar 31, 2023 | 35.97 Mn |
| Dec 31, 2022 | 39.99 Mn |
| Sep 30, 2022 | 40.12 Mn |
| Jun 30, 2022 | 32.38 Mn |
| Mar 31, 2022 | 32.33 Mn |
| Dec 31, 2021 | 34.95 Mn |
| Sep 30, 2021 | 29.97 Mn |